{
    "title": "Skulachev Ion (SkQ) - Mitochondrial Repair and Longevity",
    "inventor_name": "Vladimir Skulachev",
    "publication_year": null,
    "device_name": "SkQ1 (10-(6'-Plastoquinonyl)decyltriphenyl-phosphonium)",
    "goal": "To slow or halt biological aging and treat age-related diseases by reducing mitochondrial reactive oxygen species (ROS).",
    "problem_addressed": "Oxidative damage caused by mitochondrial ROS that contributes to cellular senescence, age-related diseases, and impaired wound healing.",
    "concept_summary": "SkQ1 is a mitochondria-targeted antioxidant composed of a penetrating cation (triphenylphosphonium) linked to a plastoquinone antioxidant moiety. The cation drives the molecule across lipid bilayers by the mitochondrial membrane potential, concentrating it inside mitochondria where it scavenges ROS and protects lipids, proteins, and DNA from oxidative damage. Pre-clinical studies show lifespan extension, vision restoration, and accelerated wound healing at nanomolar doses.",
    "detailed_description": "The SkQ1 molecule combines a lipophilic cation (triphenylphosphonium) with an antioxidant (plastoquinone) via a decyl linker. Because mitochondria have a large negative interior potential, the positively charged SkQ1 accumulates up to >1000-fold inside the organelle. At sub-micromolar concentrations SkQ1 acts as an antioxidant, being reduced by the respiratory chain and then re-oxidized, thus repeatedly scavenging ROS. In cell culture, nanomolar SkQ1 prevents H_2O_2-induced apoptosis. In animal models (mice, rats, Drosophila, crustaceans), chronic administration prolongs lifespan, reduces incidence of cataract, retinopathy, osteoporosis, and improves cardiac and renal outcomes after ischemic injury. Topical eye-drop formulations (250 nM SkQ1) restored vision in 67 of 89 blind animals. Wound-healing studies demonstrated faster granulation, reduced neutrophil infiltration, and enhanced re-epithelialization in mice and rats.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Electrophoretic accumulation driven by mitochondrial membrane potential",
        "Targeted delivery of antioxidant to mitochondria",
        "ROS scavenging and inhibition of lipid peroxidation",
        "Rechargeable antioxidant cycle via respiratory chain"
    ],
    "scientific_domains": [
        "Biochemistry",
        "Molecular Biology",
        "Pharmacology",
        "Gerontology"
    ],
    "mechanisms_of_action": [
        "Mitochondria-targeted antioxidant activity",
        "Scavenging of superoxide and other ROS",
        "Protection of cardiolipin and mitochondrial membranes",
        "Modulation of apoptosis and inflammation pathways"
    ],
    "materials": [
        "Plastoquinone",
        "Triphenylphosphonium",
        "Decyl linker",
        "SkQ1 compound (10-(6'-Plastoquinonyl)decyltriphenyl-phosphonium)"
    ],
    "energy_sources": [],
    "inputs": [
        "SkQ1 (nanomolar to micromolar concentrations)",
        "Formulations (eye drops, oral water supplementation, topical gels)",
        "Animal models (mice, rats, Drosophila, crustaceans, rabbits, dogs, cats, horses)",
        "Cell cultures (human fibroblasts, HeLa cells, keratinocytes)"
    ],
    "outputs": [
        "Reduced mitochondrial ROS levels",
        "Prevention of oxidative damage to lipids, proteins, DNA",
        "Extended lifespan in model organisms",
        "Restored vision in animal models of retinopathy",
        "Accelerated dermal wound healing",
        "Decreased incidence of age-related pathologies (cataract, osteoporosis, etc.)"
    ],
    "claimed_performance": "Nanomolar SkQ1 prevented cardiolipin oxidation, prolonged lifespan in mice and Drosophila, restored vision in 67 of 89 blind animals, and accelerated wound healing by >30 % in mice (earlier granulation and re-epithelialization).",
    "experimental_evidence": "Multiple peer-reviewed studies (Biochim Biophys Acta 2009; Biochemistry (Moscow) 2010) report in-vitro antioxidant activity, in-vivo lifespan extension, vision restoration, and wound-healing acceleration in rodents and other animals at nanomolar doses.",
    "replication_status": null,
    "keywords": [
        "SkQ1",
        "Mitochondria-targeted antioxidant",
        "Reactive oxygen species",
        "Aging",
        "Longevity",
        "Retinopathy",
        "Wound healing",
        "Plastoquinone",
        "Triphenylphosphonium"
    ],
    "related_technologies": [
        "MitoQ",
        "Coenzyme Q10 (CoQ10)",
        "Targeted antioxidant delivery systems"
    ],
    "controversy_level": "medium",
    "confidence_score": 0.9,
    "practicability_score": 0.7,
    "fringe_score": 0.2,
    "evidence_strength": 0.7,
    "risk_score": 0.2,
    "trl_estimate": 6,
    "source_urls": [
        "http://en.wikipedia.org/wiki/SkQ",
        "http://www.ncbi.nlm.nih.gov/pubmed/19159610",
        "http://en.skq-project.ru/",
        "http://www.ncbi.nlm.nih.gov/pubmed/20370605",
        "http://link.springer.com/article/10.1134%2FS000629791003003X",
        "http://www.mitoq.com/"
    ],
    "organizations": [
        "Moscow State University",
        "Mitotech (spin-off company)",
        "SkQ Project"
    ],
    "applications": [
        "Anti-aging therapeutics",
        "Ophthalmic drug for retinopathy, cataract, glaucoma",
        "Topical wound-healing agents",
        "Cardiovascular and neurodegenerative disease mitigation",
        "General oxidative-stress reduction"
    ],
    "limitations": [
        "Efficacy demonstrated primarily in animal models and cell culture",
        "Long-term safety and optimal dosing in humans not yet established",
        "Potential toxicity at higher concentrations",
        "Regulatory approval pending"
    ],
    "open_questions": [
        "Will nanomolar SkQ1 dosing be effective and safe in humans?",
        "What are the pharmacokinetics and biodistribution in clinical populations?",
        "Can SkQ1 be combined with other therapies without adverse interactions?",
        "What is the exact mechanism of lifespan extension across species?"
    ],
    "red_flags": [
        "Claims of \"anti-aging\" and \"longevity\" often attract hype and may overstate current evidence.",
        "Limited large-scale, double-blind human clinical trials reported."
    ],
    "evidence_quotes": [
        "Nanomolar SkQ1 specifically prevented oxidation of mitochondrial cardiolipin.",
        "SkQ1 prolonged lifespan in mice, Drosophila, and crustaceans, being especially effective at early and middle stages of aging.",
        "Drops containing 250 nM SkQ1 restored vision to 67 of 89 blind animals (dogs, cats, and horses).",
        "SkQ1 accelerated wound cleaning and suppressed neutrophil infiltration at the early (7 h) steps of the inflammatory phase in mice and rats.",
        "Lifelong treatment of mice with SkQ1 supplemented in drinking water strongly stimulated skin wound healing in old (28-month) animals."
    ]
}